Literature DB >> 8272402

Precision, accuracy, and data acceptance criteria in biopharmaceutical analysis.

H T Karnes1, C March.   

Abstract

Accuracy and precision are the most important criteria in the assessment of an analytical method, and monitoring quality control during sample analysis is essential to ensure the validity of reported results. Various approaches to testing accuracy, precision, and quality control were applied to 10 analytes from seven chromatographic bioanalytical methods. These methods include fixed interval bias and significance testing for accuracy; fixed interval percentage relative standard deviation (%RSD) and analysis of variance (ANOVA) approaches for precision; +/- 20% fixed range, 99% confidence interval, multiple rules, and range chart for individuals approaches for quality control acceptance criteria. Quality control approaches were also applied to the entire run and to a bracketed approach whereby results are considered valid only if bracketed by acceptable quality control. Accuracy and precision were assessed for six runs of each analyte at three concentrations established to represent the calibration range of the analytical method. Quality control acceptance criteria were evaluated using all data sets from each of the analytical methods collected during the course of running various numbers of real samples. The data suggest that the fixed interval bias criteria for accuracy was a more liberal method of accuracy assessment because three of the seven methods would have been rejected according to the significance testing criteria whereas all were acceptable by the fixed internal bias criteria. Precision can be effectively assessed for between- and within-run data by criteria set on unconfounded %RSD values or by separation of the sources of variation using an ANOVA approach applied to confounded data.(ABSTRACT TRUNCATED AT 250 WORDS)

Mesh:

Substances:

Year:  1993        PMID: 8272402     DOI: 10.1023/a:1018958805795

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  9 in total

1.  Comparing the power of quality-control rules to detect persistent systematic error.

Authors:  C A Parvin
Journal:  Clin Chem       Date:  1992-03       Impact factor: 8.327

2.  Comparing the power of quality-control rules to detect persistent increases in random error.

Authors:  C A Parvin
Journal:  Clin Chem       Date:  1992-03       Impact factor: 8.327

3.  Evaluation of criteria for the acceptance of bioanalytical data.

Authors:  A G Causey; H M Hill; L J Phillips
Journal:  J Pharm Biomed Anal       Date:  1990       Impact factor: 3.935

4.  Calibration and validation of linearity in chromatographic biopharmaceutical analysis.

Authors:  H T Karnes; C March
Journal:  J Pharm Biomed Anal       Date:  1991       Impact factor: 3.935

5.  A comprehensive method validation strategy for bioanalytical applications in the pharmaceutical industry--2. Statistical analyses.

Authors:  J R Lang; S Bolton
Journal:  J Pharm Biomed Anal       Date:  1991       Impact factor: 3.935

Review 6.  Validation of bioanalytical methods.

Authors:  H T Karnes; G Shiu; V P Shah
Journal:  Pharm Res       Date:  1991-04       Impact factor: 4.200

7.  A multi-rule Shewhart chart for quality control in clinical chemistry.

Authors:  J O Westgard; P L Barry; M R Hunt; T Groth
Journal:  Clin Chem       Date:  1981-03       Impact factor: 8.327

8.  A predictive value model for quality control: effects of the prevalence of errors on the performance of control procedures.

Authors:  J O Westgard; T Groth
Journal:  Am J Clin Pathol       Date:  1983-07       Impact factor: 2.493

9.  Principles for developing improved quality control procedures.

Authors:  J O Westgard; T Groth; C H de Verdier
Journal:  Scand J Clin Lab Invest Suppl       Date:  1984
  9 in total
  7 in total

1.  Stability-indicating LC-MS Method for Determination of Stability of Extemporaneously Compounded Buprenorphine Oral Syringes for Neonatal Abstinence Syndrome.

Authors:  Ankit Rochani; Vinh Nguyen; Robin Becker; Walter Kraft; Gagan Kaushal
Journal:  J Pediatr Pharmacol Ther       Date:  2021-05-19

2.  The enhancer effect of several phenyl alcohols on percutaneous penetration of 5-fluorouracil.

Authors:  A López; M A Pellett; F Llinares; O Díez-Sales; M Herráez; J Hadgraft
Journal:  Pharm Res       Date:  1997-05       Impact factor: 4.200

3.  A pharmacokinetic study of diclofenac sodium in rats.

Authors:  Jing Yuan; He Ma; Nannan Cen; Ai Zhou; Hengxun Tao
Journal:  Biomed Rep       Date:  2017-07-06

4.  Nonlinear intestinal absorption kinetics of cefuroxime axetil in rats.

Authors:  N Ruiz-Balaguer; A Nacher; V G Casabo; M Merino
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

5.  An improved LC-MS/MS method for quantitative determination of ilaprazole and its metabolites in human plasma and its application to a pharmacokinetic study.

Authors:  Gan Zhou; Zhi-rong Tan; Wei Zhang; Dong-sheng Ou-Yang; Yao Chen; Dong Guo; Ying-zi Liu; Lan Fan; Han-wu Deng
Journal:  Acta Pharmacol Sin       Date:  2009-08-24       Impact factor: 6.150

6.  Pharmacokinetics and biodistribution of the cyclin-dependent kinase inhibitor -CR8- in mice.

Authors:  Hatem Sallam; Ibrahim El-Serafi; Laurent Meijer; Moustapha Hassan
Journal:  BMC Pharmacol Toxicol       Date:  2013-09-30       Impact factor: 2.483

7.  A pharmacokinetic study of Isatin in Beagles' bodies.

Authors:  Ailing Ren; Benhua Su; Siyong Ye; Xia Wei; Zhaoguo Fang; Qian Wang; Jian Zhang; Wen Xu; Wang Yue; Lei Yin; Zhantao Liu; Xiaoling Li; B O Ding
Journal:  Exp Ther Med       Date:  2016-04-06       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.